MEDIA RELEASE: Embargo: Immediate release NO RADIATION EXPOSURE AT KOPANONG HOSPITAL Pretoria, 21 June 2019 – The South African Health Products Regulatory Authority (SAHPRA) can confirm that there is NO radiation exposure emanating from the Kopanong Hospital in Vereeniging. “The principal mandate of SAHPRA is to...
MEDIA RELEASE: Embargo: Immediate release Pretoria, 2 July 2019 – The South African Health Products Authority (SAHPRA) is aware of the non-medicinal use of codeine-containing medicines and is working with the relevant bodies to combat this misuse. What is Codeine? Codeine is classified as an opioid. Opioids...
MEDIA RELEASE: For immediate release SAHPRA Backlog Project – the three-pronged approach Pretoria, 22 August 2019 – The South African Health Products Regulatory Authority (SAHPRA) aims to clear its backlog within a period of two years. The backlog clearance programme went live on 1 August...
MEDICINE SAFETY ALERT: PROMETHAZINE CONTRAINDICATED IN CHILDREN UNDER TWO YEARS OF AGE ...
MEDICINE SAFETY ALERT: ATYPICAL ANTIPSYCHOTICS IN ELDERLY PATIENTS WITH DEMENTIA ...
MEDICINE SAFETY ALERT: COUGH AND COLD MEDICINES NO LONGER TO BE USED ON CHILDREN UNDER THE AGE OF TWO YEARS ...
MEDICINE SAFETY ALERT: NEW RESTRICTIONS ON THE USE OF GAMMA BENZENE HEXACHLORIDE (LINDANE) - CONTAINING SHAMPOOS ...
The South African Health Products Regulatory Authority (SAHPRA) is updating certain active pharmaceutical ingredient (API) names used in South Africa to bring them into line with international nomenclature. Further name changes are also taking place – to improve consistency within South African approved terminology and...
In South Africa, potential manufacturers of biosimilars lack a roadmap for comparing...
Issues Related to the Formulation and Delivery of Pharmaceutical Proteins ...
